Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neurofibroma, Plexiform × cabozantinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 18 Osteosarcoma 5 Neuroendocrine Tumors 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Kidney Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma, Ewing 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Medullary 2 Carcinoma 2 Adrenocortical Carcinoma 2 von Hippel-Lindau Disease 1 Wilms Tumor 1 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

mirdametinib 2 AZD 6244 2 trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡